Skip to main content

Advertisement

SpringerLink
Log in

Clinical significance of a serum CA 15-3 surge and the usefulness of CA 15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kim HS, Park YH, Park MJ et al (2009) Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer. Breast Cancer Res Treat 118:89–97

    Article  CAS  PubMed  Google Scholar 

  2. Molina R, Zanon G, Filella X et al (1995) Use of serial carcinoembryonic antigen and CA15.3 assays in detecting relapses in breast cancer patients. Breast Cancer Res Treat 36:41–48

    Article  CAS  PubMed  Google Scholar 

  3. Hou MF, Chen YL, Tseng TF et al (1999) Evaluation of serum CA27.29, CA15-3 and CEA in patients with breast cancer. Kaohsiung J Med Sci 15:520–528

    CAS  PubMed  Google Scholar 

  4. Kufe D, Inghirami G, Abe M et al (1984) Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 3:223–232

    Article  CAS  PubMed  Google Scholar 

  5. Klee GG, Schreiber WE (2004) MUC1 gene-derived glycoprotein assays for monitoring breast cancer (CA15-3, CA27.29, BR). Arch Pathol Lab Med 128:1131–1135

    CAS  PubMed  Google Scholar 

  6. Reddish MA, Helbrecht N, Almeida AF et al (1992) Epitope mapping of MAb B27.29 within the peptide core of the malignant breast carcinoma-associated mucin antigen coded for by the human MUC1 gene. J Tumor Marker Oncol 7:19–27

    Google Scholar 

  7. Gourevitch MM, Von Mensdorff-Pouilly S, Litvinov SV et al (1995) Polymorphic epithelial mucin (MUC-1)-containing circulating immunocomplexes in carcinoma patients. Br J Cancer 72:934–938

    CAS  PubMed  Google Scholar 

References for Rebuttal

  1. Kim HS, Park YH, Park MJ et al (2009) Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer. Breast Cancer Res Treat 118:89–97

    Article  CAS  PubMed  Google Scholar 

  2. Duffy MJ (2006) Serum tumor markers in breast cancer: are they of clinical value? Clin Chem 52:345–351

    Article  CAS  PubMed  Google Scholar 

  3. Hashimoto K, Yonemori K, Katsumata N, et al (2010) Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy. Ann Oncol [Epub ahead of print]

  4. Baskić D, Ristić P, Matić S et al (2007) Clinical evaluation of the simultaneous determination of CA 15-3, CA 125 and sHER2 in breast cancer. Biomarkers 12:657–667

    Article  PubMed  Google Scholar 

  5. Tampellini M, Berruti A, Bitossi R et al (2006) Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients. Breast Cancer Res Treat 98:241–248

    Article  CAS  PubMed  Google Scholar 

  6. Duffy MJ (2001) Biochemical markers in breast cancer: which ones are clinically useful? Clin Biochem 34:347–352

    Article  CAS  PubMed  Google Scholar 

  7. Mall AS (2008) Analysis of mucins: role in laboratory diagnosis. J Clin Pathol 61:1018–1024

    Article  CAS  PubMed  Google Scholar 

  8. Jonckheere N, Van Seuningen I (2010) The membrane-bound mucins: From cell signaling to transcriptional regulation and expression in epithelial cancers. Biochimie 92:1–11

    Article  CAS  PubMed  Google Scholar 

  9. Yonezawa S, Goto M, Yamada N et al (2008) Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior. Proteomics 8:3329–3341

    Article  CAS  PubMed  Google Scholar 

  10. Bafna S, Kaur S, Batra SK (2010) Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene 29:2893–2904

    Article  CAS  PubMed  Google Scholar 

  11. Vogelzang NJ, Lange PH, Goldman A et al (1982) Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors. Cancer Res 42:4855–4861

    CAS  PubMed  Google Scholar 

  12. Horwich A, Peckham MJ (1986) Transient tumor marker elevation following chemotherapy for germ cell tumors of the testis. Cancer Treat Res 70:1329–1331

    CAS  Google Scholar 

  13. Sella A, Sternberg CN, Skoneczna I et al (2008) Prostate-specific antigen flare phenomenon with docetaxel-based chemotherapy in patients with androgen-independent prostate cancer. BJU Int 102:1607–1609

    Article  CAS  PubMed  Google Scholar 

  14. Nelius T, Filleur S (2009) PSA surge/flare-up in patients with castration-refractory prostate cancer during the initial phase of chemotherapy. Prostate 69:1802–1807

    Article  CAS  PubMed  Google Scholar 

  15. De Wit R, Collette L, Sylvester R (1998) Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance. Br J Cancer 78:1350–1355

    PubMed  Google Scholar 

  16. An X, Ding PR, Xiang XJ et al (2010) Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to irinotecan combination chemotherapy. Biomarkers 15:243–248

    Article  CAS  PubMed  Google Scholar 

  17. Ailawadhi S, Sunga A, Raiput A et al (2005) Chemotherapy-induced carcinoembryonic antigen surge in patients with metastatic colorectal cancer. Oncology 70:49–53

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Chang Gung Memorial Hospital (CGMH)-Kaohsiung Medical Center, Chang Gung University of Medicine, 123, Ta-Pei Road, Niao-Sung Hsiang, Kaohsiung Hsien, Taiwan, ROC

    Shih-Chung Wu & Fong-Fu Chou

  2. Department of Oncology, Chang Gung Memorial Hospital (CGMH)-Kaohsiung Medical Center, Chang Gung University of Medicine, 123, Ta-Pei Road, Niao-Sung Hsiang, Kaohsiung Hsien, Taiwan, ROC

    Kun-Ming Rau

Authors
  1. Shih-Chung Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fong-Fu Chou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kun-Ming Rau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shih-Chung Wu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, SC., Chou, FF. & Rau, KM. Clinical significance of a serum CA 15-3 surge and the usefulness of CA 15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer. Breast Cancer Res Treat 124, 879–882 (2010). https://doi.org/10.1007/s10549-010-1117-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-1117-3

Keywords

Search

Navigation